WASHINGTON, DC / ACCESS Newswire / June 23, 2025 / The U.S. Drug Enforcement Administration (DEA) continues to obstruct legally compliant cannabis research for debilitating conditions like Multiple Sclerosis (MS) and Huntington’s Disease (HD)-even as marijuana distribution networks tied to tribal transit operations in North Carolina move quantities of cannabis across state lines with little to no DEA enforcement.
Read More: DEA Stops Cannabis Research; Tribes Transiting Unchecked
Comments are closed, but trackbacks and pingbacks are open.